Genomewide comprehensive analysis reveals critical cooperation between smad and c-Fos in RANKL-induced osteoclastogenesis

Journal of Bone and Mineral Research

Volumn 30, Issue 5, 2015, Pages 869-877

  Omata, Yasunori ^a   Yasui, Tetsuro ^a   Hirose, Jun ^a   Izawa, Naohiro ^a   Imai, Yuuki ^b   Matsumoto, Takumi ^a   Masuda, Hironari ^a   Tokuyama, Naoto ^a   Nakamura, Shinya ^a   Tsutsumi, Shuichi ^c   Yasuda, Hisataka ^d   Okamoto, Kazuo ^a,f   Takayanagi, Hiroshi ^a,f   Hikita, Atsuhiko ^b   Imamura, Takeshi ^b   Matsuo, Koichi ^e   Saito, Taku ^a   Kadono, Yuho ^a   Aburatani, Hiroyuki ^c   Tanaka, Sakae ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Oriental Yeast Co Ltd   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cell tissue signaling; Cytokines; Molecular pathways; Osteoclast; Transcription factors

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; NUCLEAR FACTOR OF ACTIVATED T CELL CYTOPLASMIC 1; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CHROMATIN; NFATC1 PROTEIN, MOUSE; PROTEIN BINDING; SMAD PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEAR IMPORT; OSTEOCLASTOGENESIS; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY SEQUENCE; SIGNAL TRANSDUCTION; ANIMAL; BONE DEVELOPMENT; CYTOLOGY; DRUG EFFECTS; GENETICS; GENOME; HUMAN; METABOLISM; OSTEOCLAST;

ANIMALS; CHROMATIN; GENOME; HUMANS; MALE; MICE; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; OSTEOGENESIS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; RANK LIGAND; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84927747957     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2418     Document Type: Article

References (37)

1. Tanaka S,. Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system. Am J Nephrol. 2007; 27 (5): 466-478.
2. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93 (2): 165-176.
3. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ,. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999; 20 (3): 345-357.
4. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor,is identical to TRANCE/RANKL. Proc Natl Acad Sci U S.A. 1998; 95 (7): 3597-3602.
5. Yasui T, Hirose J, Tsutsumi S, Nakamura K, Aburatani H, Tanaka S,. Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1. J Bone Miner Res. 2011; 26 (11): 2665-2671.
6. Fox SW, Haque SJ, Lovibond AC, Chambers TJ,. The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro. J Immunol. 2003; 170 (7): 3679-3687.
7. Massague J, Attisano L, Wrana JL,. The TGF-beta family and its composite receptors. Trends Cell Biol. 1994; 4 (5): 172-178.
8. Li MO, Flavell RA,. A master of all T cell trades. Cell. 2008; 134 (3): 392-404.
9. Graff JM, Bansal A, Melton DA,. Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily. Cell. 1996; 85 (4): 479-487.
10. Derynck R, Zhang YE,. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003; 425 (6958): 577-584.
11. Baker JC, Harland RM,. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 1996; 10 (15): 1880-1889.
12. Massague J, Gomis RR,. The logic of TGFbeta signaling. FEBS Lett. 2006; 580 (12): 2811-2820.
13. Shi Y, Massague J,. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003; 113 (6): 685-700.
14. Giresi PG, Lieb JD,. Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (formaldehyde assisted isolation of regulatory elements). Methods. 2009; 48 (3): 233-239.
15. Yasui T, Kadono Y, Nakamura M, et al. Regulation of RANKL-induced osteoclastogenesis by TGF-beta through molecular interaction between Smad3 and Traf6. J Bone Miner Res. 2011; 26 (7): 1447-1456.
16. Sasaki T, Kojima H, Kishimoto R, Ikeda A, Kunimoto H, Nakajima K,. Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol Cell. 2006; 24 (1): 63-75.
17. Ishida N, Hayashi K, Hoshijima M, et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem. 2002; 277 (43): 41147-41156.
18. Takayanagi H, Kim S, Koga T, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002; 3 (6): 889-901.
19. Tondravi MM, McKercher SR, Anderson K, et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU. 1. Nature. 1997; 386 (6620): 81-84.
20. Mansky KC, Marfatia K, Purdom GH, Luchin A, Hume DA, Ostrowski MC,. The microphthalmia transcription factor (MITF) contains two N-terminal domains required for transactivation of osteoclast target promoters and rescue of mi mutant osteoclasts. J Leukoc Biol. 2002; 71 (2): 295-303.
21. Sharma SM, Bronisz A, Hu R, et al. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J Biol Chem. 2007; 282 (21): 15921-15929.
22. Sims RJ, 3rd, Belotserkovskaya R, Reinberg D,. Elongation by RNA polymerase II: the short and long of it. Genes Dev. 2004; 18 (20): 2437-2468.
23. Core LJ, Lis JT,. Transcription regulation through promoter-proximal pausing of RNA polymerase II. Science. 2008; 319 (5871): 1791-1792.
24. Hua X, Liu X, Ansari DO, Lodish HF,. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 1998; 12 (19): 3084-3095.
25. Zhou S, Zawel L, Lengauer C, Kinzler KW, Vogelstein B,. Characterization of human FAST-1, a TGF beta and activin signal transducer. Mol Cell. 1998; 2 (1): 121-127.
26. Hanai J, Chen LF, Kanno T, et al. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem. 1999; 274 (44): 31577-31582.
27. Jochum W, Passegue E, Wagner EF,. AP-1 in mouse development and tumorigenesis. Oncogene. 2001; 20 (19): 2401-2412.
28. Johnson RS, Spiegelman BM, Papaioannou V,. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell. 1992; 71 (4): 577-586.
29. Wang ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF,. Bone and haematopoietic defects in mice lacking c-fos. Nature. 1992; 360 (6406): 741-745.
30. Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF,. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet. 2000; 24 (2): 184-187.
31. Matsuo K, Galson DL, Zhao C, et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem. 2004; 279 (25): 26475-26480.
32. Zhang Y, Feng XH, Derynck R,. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature. 1998; 394 (6696): 909-913.
33. Norwitz ER,., Xu S, Xu J, et al. Direct binding of AP-1 (Fos/Jun) proteins to a SMAD binding element facilitates both gonadotropin-releasing hormone (GnRH)- and activin-mediated transcriptional activation of the mouse GnRH receptor gene. J Biol Chem. 2002; 277 (40): 37469-37478.
34. Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang XF,. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol. 1997; 17 (12): 7019-7028.
35. Sundqvist A, Zieba A, Vasilaki E, et al. Specific interactions between Smad proteins and AP-1 components determine TGFbeta-induced breast cancer cell invasion. Oncogene. 2013; 32 (31): 3606-3615.
36. Biddie SC, John S, Sabo PJ, et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell. 2011; 43 (1): 145-155.
37. Song L, Zhang Z, Grasfeder LL, et al. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res. 2011; 21 (10): 1757-1767.